WallStreetZenWallStreetZen

NASDAQ: CRSP
Crispr Therapeutics Ag Stock Forecast, Predictions & Price Target

Analyst price target for CRSP

Based on 10 analysts offering 12 month price targets for Crispr Therapeutics Ag.
Min Forecast
$30.00-57.24%
Avg Forecast
$83.50+19.01%
Max Forecast
$160.00+128.05%

Should I buy or sell CRSP stock?

Based on 10 analysts offering ratings for Crispr Therapeutics Ag.
Buy
Strong Buy
3 analysts 30%
Buy
2 analysts 20%
Hold
3 analysts 30%
Sell
1 analysts 10%
Strong Sell
1 analysts 10%

Be the first to know when Wall Street analysts revise their CRSP stock forecasts and price targets.

CRSP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-06
lockedlocked$00.00+00.00%2024-02-26
lockedlocked$00.00+00.00%2024-02-22
lockedlocked$00.00+00.00%2024-02-22
lockedlocked$00.00+00.00%2024-02-22
Chardan Capital
Top 3%
98
Strong BuyMaintains$112.00+59.64%2024-02-22
Needham
Top 1%
100
BuyMaintains$90.00+28.28%2024-02-21
Truist Securities
Top 3%
98
Strong BuyMaintains$160.00+128.05%2023-12-11
TD Cowen
Bottom 5%
5
SellDowngrades$30.00-57.24%2023-12-11
JMP Securities
Top 20%
81
BuyMaintains$80.00+14.03%2023-12-11

1 of 1

Forecast return on equity

Is CRSP forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.5%

Forecast return on assets

Is CRSP forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CRSP revenue forecast

What is CRSP's revenue in the next 3 years based on estimates from 11 analysts?
Avg 1 year Forecast
$105.4M-71.6%
Avg 2 year Forecast
$567.2M+52.81%
Avg 3 year Forecast
$1.4B+278.15%
CRSP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CRSP revenue growth forecast

How is CRSP forecast to perform vs Biotechnology companies and vs the US market?
Company
52.2%
Industry
38.94%
Market
10.52%
CRSP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CRSP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CRSP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CRSP$70.16$83.50+19.01%Buy
BPMC$94.79$89.10-6.00%Buy
BBIO$30.86$49.67+60.94%Strong Buy
RVMD$31.72$38.70+22.01%Strong Buy
HALO$40.73$54.17+32.99%Buy

Crispr Therapeutics Ag Stock Forecast FAQ

Is Crispr Therapeutics Ag Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NASDAQ: CRSP) stock is to Buy CRSP stock.

Out of 10 analysts, 3 (30%) are recommending CRSP as a Strong Buy, 2 (20%) are recommending CRSP as a Buy, 3 (30%) are recommending CRSP as a Hold, 1 (10%) are recommending CRSP as a Sell, and 1 (10%) are recommending CRSP as a Strong Sell.

If you're new to stock investing, here's how to buy Crispr Therapeutics Ag stock.

What is CRSP's revenue growth forecast for 2024-2026?

(NASDAQ: CRSP) Crispr Therapeutics Ag's forecast annual revenue growth rate of 52.2% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Crispr Therapeutics Ag's revenue in 2024 is $371,206,000.On average, 11 Wall Street analysts forecast CRSP's revenue for 2024 to be $8,461,807,614, with the lowest CRSP revenue forecast at $1,766,070,900, and the highest CRSP revenue forecast at $36,758,357,505. On average, 10 Wall Street analysts forecast CRSP's revenue for 2025 to be $45,534,846,843, with the lowest CRSP revenue forecast at $5,539,040,550, and the highest CRSP revenue forecast at $265,857,891,210.

In 2026, CRSP is forecast to generate $112,685,839,569 in revenue, with the lowest revenue forecast at $31,715,422,326 and the highest revenue forecast at $436,950,023,445.

What is CRSP's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CRSP) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CRSP's Price Target?

According to 10 Wall Street analysts that have issued a 1 year CRSP price target, the average CRSP price target is $83.50, with the highest CRSP stock price forecast at $160.00 and the lowest CRSP stock price forecast at $30.00.

On average, Wall Street analysts predict that Crispr Therapeutics Ag's share price could reach $83.50 by Mar 6, 2025. The average Crispr Therapeutics Ag stock price prediction forecasts a potential upside of 19.01% from the current CRSP share price of $70.16.

What is CRSP's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CRSP) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.